Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons

• المؤلفون الرئيسيون: Tremblay G (مؤلف), Westley T (مؤلف), Cappelleri JC (مؤلف), Arondekar B (مؤلف), Chan G (مؤلف), Bell TJ (مؤلف), Briggs A (مؤلف)
• التنسيق: كتاب
• منشور في: Dove Medical Press, 2019-09-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Gabriel Tremblay1, Tracy Westley1, Joseph C Cappelleri2, Bhakti Arondekar2, Geoffrey Chan2, Timothy J Bell2, Andrew Briggs3 1Purple Squirrel Economics, New York, NY, USA; 2Pfizer Inc, New York, NY, USA; 3William R Lindsay Chair of Health Economics, Health Economics and Technology Assessment, Institu...